Evidence map›Paper›PMID 21976667›Full record

ArticleThe Journal of biological chemistry2011

Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron.

Jason R Hickok, Sumit Sahni, Yuliya Mikhed, Marcelo G Bonini, Douglas D Thomas

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Triple Crown: NO, CO, and HPharmacology & therapeutics · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. The Relationship of Glutathione-Molecules (Basel, Switzerland) · 2021
    Review
  11. The Role of Nitric Oxide in Cancer: Master Regulator or NOt?International journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
  14. Chemical science · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jason R HickokDepartments of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago, Illinois 60612.
Sumit SahniDepartments of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago, Illinois 60612.
Yuliya MikhedDepartments of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago, Illinois 60612.
Marcelo G BoniniDepartments of Medicine and Pharmacology, University of Illinois, Chicago, Illinois 60612.
Douglas D ThomasDepartments of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago, Illinois 60612. Electronic address: ddthomas@uic.edu.
University of Illinois Chicago · US

Funding

The role of dinitrosyliron complexes in cancer etiologyR01GM094175 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI THOMAS, DOUGLAS D. · 2011 to 2014
$978k
Hypoxia controls nitric oxide-regulated proteinsK22CA113315 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI THOMAS, DOUGLAS D. · 2007 to 2009
$484k
NCI NIH HHS K22 CA113315NCI NIH HHS K22CA113315NIGMS NIH HHS R01 GM094175
6 · The paper itself

Abstract

N-Myc downstream-regulated gene 1 (NDRG1) is a ubiquitous cellular protein that is up-regulated under a multitude of stress and growth-regulatory conditions. Although the exact cellular functions of this protein have not been elucidated, mutations in this gene or aberrant expression of this protein have been linked to both tumor suppressive and oncogenic phenotypes. Previous reports have demonstrated that NDRG1 is strongly up-regulated by chemical iron chelators and hypoxia, yet its regulation by the free radical nitric oxide ((•)NO) has never been demonstrated. Herein, we examine the chemical biology that confers NDRG1 responsiveness at the mRNA and protein levels to (•)NO. We demonstrate that the interaction of (•)NO with the chelatable iron pool (CIP) and the appearance of dinitrosyliron complexes (DNIC) are key determinants. Using HCC 1806 triple negative breast cancer cells, we find that NDRG1 is up-regulated by physiological (•)NO concentrations in a dose- and time-dependant manner. Tumor cell migration was suppressed by NDRG1 expression and we excluded the involvement of HIF-1α, sGC, N-Myc, and c-Myc as upstream regulatory targets of (•)NO. Augmenting the chelatable iron pool abolished (•)NO-mediated NDRG1 expression and the associated phenotypic effects. These data, in summary, reveal a link between (•)NO, chelatable iron, and regulation of NDRG1 expression and signaling in tumor cells.

Indexed as

Breast NeoplasmsCell Cycle ProteinsCell Line, TumorCell MovementDose-Response Relationship, DrugFemaleFree Radical ScavengersGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitIntracellular Signaling Peptides and ProteinsIronNitric OxideNitrogen OxidesN-myc Downstream-Regulated Gene 1 ProteinProto-Oncogene Proteins c-mycCell Cycle Proteinsdinitrosyl iron complexFree Radical ScavengersHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIntracellular Signaling Peptides and ProteinsIronMYC protein, humanNitric OxideNitrogen OxidesN-myc Downstream-Regulated Gene 1 ProteinProto-Oncogene Proteins c-myc

Identifiers

PMID21976667
PMCPMC3308853
OpenAlexW2020603912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.